Debrisoquine
Подписчиков: 0, рейтинг: 0
|
| |
| Names | |
|---|---|
|
Preferred IUPAC name
3,4-Dihydroisoquinoline-2(1H)-carboximidamide | |
| Identifiers | |
|
3D model (JSmol)
|
|
| ChEBI | |
| ChEMBL | |
| ChemSpider |
|
| DrugBank |
|
| ECHA InfoCard | 100.013.155 |
| KEGG |
|
| MeSH | Debrisoquine |
|
PubChem CID
|
|
| UNII | |
|
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C10H13N3 | |
| Molar mass | 175.23032 |
| Pharmacology | |
| C02CC04 (WHO) | |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Debrisoquine is a derivative of guanidine. It is an antihypertensive drug similar to guanethidine. Debrisoquine is frequently used for phenotyping the CYP2D6 enzyme, a drug-metabolizing enzyme.
See also
The guanidine part of the molecule also appears in guanoxan and guanadrel.
- The 7-bromo analog of Debrisoquine is called Guanisoquin.
|
Sympatholytics (antagonize α-adrenergic vasoconstriction) |
|||||
|---|---|---|---|---|---|
| Other antagonists |
|
||||
| |||||